![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Synthon Bv Nijmegen Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Pramipexole dihydrochloride monohydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-375 - Rev 00
This Chemical Type CEP, issued on May 30, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2416 associated with this CEP further emphasizes